Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GMP Rule’s Returned Product Testing Provision Is Overly Restrictive – NBTY
Sep 01 2003
•
By
The Tan Sheet
More from Archive
More from Pink Sheet